Laryngeal NUT Carcinoma With BRD4 :: NUTM1 Fusion: A 4‐Year Clinical Course Highlighting the Limitations of Current Multimodal Therapy
Open Access
- 8 September 2026
- journal article
- case report
- Published by Wiley in Cancer Reports
- Vol. 9 (9) , e70679
Abstract
Background: Nuclear protein in testis (NUT) carcinoma is a rare, aggressive malignancy driven by NUTM1 rearrangement, often misdiagnosed as squamous cell carcinoma, with no established standard therapy. This report describes the clinical course and treatment resistance in primary laryngeal NUT carcinoma and provides insights into potential mechanism‐based therapeutic approaches. Case: A 30‐year‐old man with a laryngeal tumor was initially treated for poorly differentiated squamous cell carcinoma. Recurrent disease prompted re‐evaluation; NUT carcinoma was diagnosed by NUT immunohistochemistry, and the BRD4 :: NUTM1 fusion was confirmed by molecular analysis. A bromodomain and extra‐terminal (BET) inhibitor and alternating vincristine, doxorubicin, and cyclophosphamide (VDC)/ifosfamide and etoposide (IE) chemotherapy induced transient tumor regression, whereas vorinostat, immune checkpoint inhibitors, and other systemic therapies were ineffective. Disease progression was ultimately driven by uncontrolled locoregional recurrence. Autopsy revealed a massive infiltrative tumor with extensive locoregional invasion, whereas distant metastatic disease was limited to minute pulmonary nodules; death resulted from overwhelming infection secondary to uncontrolled locoregional progression rather than systemic metastasis. Conclusion: Early molecular diagnosis and biologically informed multimodal strategies are essential for managing laryngeal NUT carcinoma and overcoming treatment resistance.Keywords
This publication has 36 references indexed in Scilit:
- Several Considerations on the Pathology, Treatment, and Prognosis of Laryngeal NUT CarcinomaOncology and Therapy, 2026
- Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature reviewCancer/Radiothérapie, 2024
- Nuclear protein in testis carcinoma of the lungTranslational Oncology, 2023
- Current status in the discovery of dual BET/HDAC inhibitorsBioorganic & Medicinal Chemistry Letters, 2021
- Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparationsCancer Cytopathology, 2020
- Systemic therapy in non-conventional cancers of the larynxOral Oncology, 2018
- Transcriptional Addiction in CancerCell, 2017
- Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neckCancer, 2016
- NUT Gene Rearrangement in a Poorly-differentiated Carcinoma of the Submandibular GlandHead and Neck Pathology, 2010
- Upper respiratory tract carcinoma with chromosomal translocation 15;19Cancer, 2001